Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Specimen Handling 78Cisplatin 66Carboplatin 64Drug Therapy 63Magnetic Resonance Spectroscopy 62Bevacizumab 62Radiotherapy 57Cyclophosphamide 56Gemcitabine 54pembrolizumab 52Capecitabine 50Oxaliplatin 49toripalimab 45Paclitaxel 41tislelizumab 40Standard of Care 39Biopsy 37fludarabine 36Injections 36Fluorouracil 34venetoclax 33Blood Specimen Collection 31Immune Checkpoint Inhibitors 30anlotinib 29Docetaxel 28Surgical Procedures, Operative 27Leucovorin 27Irinotecan 27Dexamethasone 27Nivolumab 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × gimeracil × 1 year × Clear all
NCT07262567 2025-12-03

Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer

Genfleet Therapeutics (Shanghai) Inc.

Phase 3 Not yet recruiting
320 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡